Anthony Defino

LAS VEGAS — OLN324, a VEGF and Ang-2 inhibitor for wet age-related macular degeneration , achieved improvements in anatomy and retinal fluid that

There is no perfect time to start a family as a busy ophthalmologist . However, motherhood is an important job, and women in medicine should never feel the need to apologize for it.

CHICAGO — Women leaders are still underrepresented in medicine, so now is the perfect time for them to redefine what strong leadership looks like within their communities, according to a speaker at the Women in Medicine Summit.

Preventing blindness worldwide requires teamwork between industry veterans and ophthalmologists who are willing to offer their time to strengthen education across the globe.

In the ever-evolving world of AI, cybersecurity threats are becoming more sophisticated than ever. If a medical practice is going to be protected, it will take company-wide effort.

The myopia epidemic continues to pose a significant international challenge, but the eye care community has made strides in reducing its progression in pediatric patients.

In October 2025, the FDA issued a complete response letter to Sydnexis regarding SYD-101, an investigational formulation of low-dose atropine

NEW ORLEANS — In the high-stakes environment of ocular surgery, stress management is a trainable skill that can be improved with strategic planning and practice, according to a speaker.

NEW ORLEANS — Verily Health has partnered with Bausch + Lomb to expand Verily Me, its consumer health app, into eye health for the first time.

Key takeaways: The approval was supported by data from the pivotal phase 3 VEGA-2 and VEGA-3 clinical trials.